NCT06752720View on ClinicalTrials.gov

Intracerebral Autologous Stem Cell Therapy for Chronic Stroke Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

November 30, 2027

Conditions
StrokeStroke, IschemicStroke; Sequelae
Interventions
DRUG

Stem cell Transplantation

Manufactured autologous mescenchymal stem cell (HUNS001-01) in our cell processing center will be injected into the brain, totally 4 x 10\^7 cells, in 2 brain sites.

Trial Locations (1)

0608638

RECRUITING

Hokkaido University Hospital, Sapporo

All Listed Sponsors
collaborator

RAINBOW Inc.

UNKNOWN

lead

Hokkaido University Hospital

OTHER